1. Home
  2. AAM vs ALT Comparison

AAM vs ALT Comparison

Compare AAM & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AAM
  • ALT
  • Stock Information
  • Founded
  • AAM 2024
  • ALT 1997
  • Country
  • AAM United States
  • ALT United States
  • Employees
  • AAM N/A
  • ALT N/A
  • Industry
  • AAM
  • ALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • AAM
  • ALT Health Care
  • Exchange
  • AAM Nasdaq
  • ALT Nasdaq
  • Market Cap
  • AAM 440.6M
  • ALT 457.0M
  • IPO Year
  • AAM 2024
  • ALT N/A
  • Fundamental
  • Price
  • AAM $10.06
  • ALT $7.49
  • Analyst Decision
  • AAM
  • ALT Buy
  • Analyst Count
  • AAM 0
  • ALT 6
  • Target Price
  • AAM N/A
  • ALT $18.80
  • AVG Volume (30 Days)
  • AAM 302.6K
  • ALT 1.9M
  • Earning Date
  • AAM 01-01-0001
  • ALT 11-12-2024
  • Dividend Yield
  • AAM N/A
  • ALT N/A
  • EPS Growth
  • AAM N/A
  • ALT N/A
  • EPS
  • AAM N/A
  • ALT N/A
  • Revenue
  • AAM N/A
  • ALT $409,000.00
  • Revenue This Year
  • AAM N/A
  • ALT N/A
  • Revenue Next Year
  • AAM N/A
  • ALT N/A
  • P/E Ratio
  • AAM N/A
  • ALT N/A
  • Revenue Growth
  • AAM N/A
  • ALT N/A
  • 52 Week Low
  • AAM $9,600.00
  • ALT $2.32
  • 52 Week High
  • AAM $15,000.00
  • ALT $14.84
  • Technical
  • Relative Strength Index (RSI)
  • AAM N/A
  • ALT 66.27
  • Support Level
  • AAM N/A
  • ALT $6.45
  • Resistance Level
  • AAM N/A
  • ALT $7.20
  • Average True Range (ATR)
  • AAM 0.00
  • ALT 0.40
  • MACD
  • AAM 0.00
  • ALT 0.08
  • Stochastic Oscillator
  • AAM 0.00
  • ALT 80.00

About AAM AA Mission Acquisition Corp. Class A Ordinary Shares

AA Mission Acquisition Corp is a blank check company.

About ALT Altimmune Inc.

Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.

Share on Social Networks: